Seek medical advice if fatigue: Persists beyond several months without improvement, despite adequate nutrition and hydration Worsens progressively or becomes debilitating, significantly impairing daily activities or work capacity Is accompanied by severe or persistent gastrointestinal symptoms (intractable nausea, vomiting, diarrhoea, abdominal pain) Occurs alongside signs of dehydration (dark urine, dizziness, reduced urine output, dry mouth) Is associated with symptoms of hypoglycaemia (tremor, sweating, confusion, palpitations), particularly in patients taking concurrent insulin or sulphonylureas Urgent medical attention is required if patients experience: Severe abdominal pain , especially if radiating to the back, which may indicate pancreatitisa rare but serious adverse effect of GLP-1 medications

Efsubaglutide alfa was approved in 2025 by China's National Medical Products Administration for type 2 diabetes and added to the national reimbursement list from January 2026, supporting hospital access
It contains low molecular weight NAC (N-acetyl L-cysteine), a glutathione precursor that helps to replenish intracellular glutathione Ishin Glutathione is also enriched with collagen (derived from Salmon Ovary Peptide), which helps increase skin radiance and hydration while diminishing the appearance of fine lines and wrinkles
Longevity & cellular aging Investigated for its role in cellular aging, since NAD+ levels decline with age in preclinical and observational research
transdermal bioavailability profiles may differ GLP-1 Terminology Clarification NuraPatch states that its patches do not contain prescription GLP-1 medications such as semaglutide or tirzepatide
Tirzepatide is a dual-action medication that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), making it slightly more effective for weight loss than semaglutide